Test my supply
71%
Finnrick rating
#184 of 301 ranked vendors
59 of 70 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Zenith Jove Peptide ZJ's Purity focus record is strongest in Retatrutide and GHK-Cu, where repeated recent identity and high-purity passes outweigh limited traceability. Tirzepatide and BPC-157 show rebound after earlier misses, while TB-500 remains dispersed with two purity failures; uneven batch IDs temper the evidence.

methodology →
vendor intelligence report
Vendor Intelligence Report: Zenith Jove Peptide ZJ

We investigated who actually operates Zenith Jove Peptide ZJ — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

23 pages7 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
93%
7
2
Retatrutide
$0.95
89%
24
3
Tirzepatide
$0.47
75%
24
4
BPC-157
$0.65
70%
9
5
Tesamorelin
$2.22
50%
2
6
TB-500
$1.90
39%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%26 Feb 2026: 67%2 Mar 2026: 63%2 Mar 2026: 65%2 Mar 2026: 66%2 Mar 2026: 66%3 Mar 2026: 65%6 Mar 2026: 66%13 Mar 2026: 66%18 Mar 2026: 66%19 Mar 2026: 66%19 Mar 2026: 67%21 Mar 2026: 67%21 Mar 2026: 67%25 Mar 2026: 68%29 Mar 2026: 68%23 Apr 2026: 68%23 Apr 2026: 68%23 Apr 2026: 69%23 Apr 2026: 69%27 Apr 2026: 68%28 Apr 2026: 68%5 May 2026: 68%5 May 2026: 69%5 May 2026: 69%5 May 2026: 69%5 May 2026: 69%6 May 2026: 70%25 May 2026: 70%8 Jun 2026: 71%8 Jun 2026: 71%1 Jul 2026: 71%22 Jul 2026: 71%22 Jul 2026: 71%22 Jul 2026: 71%22 Jul 2026: 72%22 Jul 2026: 72%22 Jul 2026: 71%22 Jul 2026: 71%22 Jul 2026: 71%4 Aug 2026: 70%10 Aug 2026: current 71%67%69%71%Feb 26Aug 26
Test my supply
Zenith Jove Peptide ZJ test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
4 Aug 2026Fail
Retatrutide
lab nameView COA
22 Jul 2026Pass
GHK-Cu
lab nameView COA
22 Jul 2026Pass
BPC-157
lab nameView COA
22 Jul 2026Pass
GHK-Cu
lab nameView COA
22 Jul 2026Pass
Retatrutide
lab nameView COA
22 Jul 2026Pass
Retatrutide
lab nameView COA
22 Jul 2026Fail
Tirzepatide
lab nameView COA
22 Jul 2026Fail
Tirzepatide
lab nameView COA
22 Jul 2026Pass
BPC-157
lab nameView COA
1 Jul 2026Pass
Retatrutide
lab nameView COA
1-10 of 70

About Zenith Jove Peptide ZJ test results from Finnrick

Zenith Jove Peptide ZJ is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 70 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Zenith Jove Peptide ZJ peptides in this dataset are BPC-157 (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 70 recent tests.

Corrections
No corrections.
Test my supply